Work

Investing in early-stage stem cell therapy developers

Year: 2025

Type: article

Abstract: “Providing a future, healthy, and competitive commercial cell therapy landscape depends on young companies having early access to sufficient capital to advance new transformational and complementary cell therapies.”

Source: Cell and Gene Therapy Insights

DOI: 10.18609/cgti.2025.023

Authors: Stijn Heessen, Kristian Tryggvason

Language: English

Topic: Private Equity and Venture Capital

Subfield: Accounting

Field: Business, Management and Accounting

Domain: Social Sciences

Open Access status: hybrid

OpenAlex ID: W4417330153

FWCI:

Cites:

Cited by:

Related to: